The Toxicology of Bath Salts: A Review of Synthetic Cathinones

Journal of Medical Toxicology

Volumn 8, Issue 1, 2012, Pages 33-42

  Prosser, Jane M ^a   Nelson, Lewis S ^b  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bath salts; Cathinone; MDPV; Mephedrone; Methedrone; Methylone

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4' METHYLMETHCATHINONE; AMFEBUTAMONE; AMINOKETONE; BENZODIAZEPINE; BUTYLONE; CATHINONE; ETHYLONE; METHAMPHETAMINE; METHCATHINONE; METHEDRONE; METHYLENEDIOXYPYROVALERONE; METHYLONE; PYROVALERONE; SEROTONIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ADVERSE OUTCOME; ARTICLE; CADAVER; CATHA EDULIS; DEPRESSION; DOSE RESPONSE; DRUG ABUSE PATTERN; DRUG BILE LEVEL; DRUG DEPENDENCE; DRUG EFFECT; DRUG INTOXICATION; DRUG LEGISLATION; DRUG LIVER LEVEL; DRUG MECHANISM; DRUG METABOLISM; DRUG STRUCTURE; DRUG TRAFFIC; FATALITY; FATIGUE; HEALTH HAZARD; HUMAN; HYPONATREMIA; LETHARGY; MULTIPLE DRUG ABUSE; NEUROMODULATION; NONHUMAN; OBESITY; PLANT LEAF; PREDICTION; RESTLESSNESS; SEIZURE; SINGLE DRUG DOSE; TOXICITY TESTING; TOXICOKINETICS; WITHDRAWAL SYNDROME;

ALKALOIDS; HUMANS; METHAMPHETAMINE; PREVALENCE; PSYCHOTROPIC DRUGS; STREET DRUGS; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS;

EID: 84857800731     PISSN: 15569039     EISSN: 19376995     Source Type: Journal    
DOI: 10.1007/s13181-011-0193-z     Document Type: Article

References (72)

1. James D, Adams RD, Spears R et al (2010) Clinical characteristics of mephedrone toxicity reported to the UK National Poisons Information Service. Emerg Med J. Epub ahead of print.
2. Google. Insights for search (2011) http://www. google. com/insights/search/. Last accessed 7/1/2011.
3. Al-Motarreb A, Al-Habori M, Broadley KJ (2010) Khat chewing, cardiovascular disease and other internal medical problems; the current situation and directions for future research. J Ethnopharmacol 132: 540-548.
4. Hyde JF, Browning E, Adams R (1928) Synthetic homologs of d, l-ephedrine. J Am Chem Soc 50(8): 2287-2292.
5. Saem de Burnaga Sanchez J (1929) Sur un homologue de la Societé Chimique de France. 45: 284-6.
6. Advisory Council on the Misuse of Drugs. Consideration of the cathinones. http://www. homeoffice. gov. uk/publications/alcohol-drugs/drugs/acmd1/acmd-cathinodes-report-2010?view=Binary. Last accessed 7/1/2010.
7. Emerson TS, Cisek JE (1993) Methcathinone: a Russian designer amphetamine infiltrates the rural Midwest. Ann Emerg Med 22(12): 1897-1903.
8. Gardos G, Cole JO (1971) Evaluation of pyrovalerone in chronically fatigued volunteers. Curr Ther Res Clin Exp 13(10): 631-635.
9. Goldberg J, Gardos G, Cole JO (1973) A controlled evaluation of pyrovalerone in chronically fatigued volunteers. Int Pharmacopsychiatry 8(1): 60-69.
10. Kriikku P, Wilhelm L, Schwarz O, Rintatalo J (2011) New designer drug of abuse: 3, 4-methylenedioxypyrovalerone (MDPV). Findings from apprehended drivers in Finland. Forensic Sci Int 210(1-3): 195-200.
11. Psychonaut WebMapping Research Group (2009) Mephedrone. Report. London, UK, Institute of Psychiatry, King's College London.
12. Archer RP (2009) Fluoromethcathinone, a new substance of abuse. Forensic Sci Int 185(1-3): 10-20.
13. Centers for Disease Control and Prevention (2011) Emergency department visits after use of a drug sold as "bath salts"-Michigan, November 13, 2010-March 31, 2011. MMWR Morb Mortal Wkly Rep 60(19): 624-627.
14. The Poison Review. http://www. thepoisonreview. com/2010/11/30/2093/. Last accessed 6/10/2001.
15. Measham F, Moore K, Newcombe R, Welch Z (2010) Tweaking, bombing, dabbing and stockpiling: the emergence of mephedrone and the perversity of prohibition. Drug Alcohol Today 10(1): 14-21.
16. Brunt TM, Poortman A, Niesink RJ, van den Brink W (2010) Instability of the ecstasy market and a new kid on the block: mephedrone. J Psychopharmacol. Epub ahead of print.
17. Winstock AR, Mitcheson LR, Deluca P et al (2011) Mephedrone, new kid for the chop? Addiction 106(1): 154-161.
18. Dargan PI, Albert S, Wood DM (2010) Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change. QJM 103(11): 875-879.
19. McNamara S, Stokes S, Coleman N (2010) Head shop compound abuse amongst attendees of the Drug Treatment Centre Board. Int Med J 103(5): 134-137.
20. American Association of Poison Control Centers. www. aapcc. org./dnn/default. aspx. Last accessed 7/10/2010.
21. Ramsey J, Dargan PI, Smyllie M et al (2010) Buying 'legal' recreational drugs does not mean that you are not breaking the law. QJM 103(10): 777-783.
22. Brandt SD, Sumnall HR, Measham F, Cole J (2010) Second generation mephedrone. The confusing case of NRG-1. BMJ 341: c3564.
23. The Misuse of Drugs (Amendment) (England, Wales and Scotland) Regulations 2010. http://www. legislation. gov. uk/uksi/2010/1144/made. Last accessed 7/22/2010.
24. Davies S, Wood DM, Smith G et al (2010) Purchasing 'legal highs' on the Internet-is there consistency in what you get? QJM 103(7): 489-493.
25. Winstock AR, Mitcheson LR, Marsden J (2010) Mephedrone: still available and twice the price. Lancet 376(9752): 1537.
26. EMCDDA-Europol joint report on mephedrone. http://www. emcdda. europa. eu/online/annual-report/2010/boxes/p92. Last accessed 7/12/2010.
27. Carhart-Harris RL, King LA, Nutt DJ (2011) A web-based survey on mephedrone. Drug Alcohol Depend. Epub ahead of print.
28. Newcombe R (2009) Mephedrone: use of mephedrone (M-Cat, Meow) in Middlesbrough. Lifeline, Manchester, UK.
29. Wood DM, Davies S, Puchnarewicz M et al (2010) Recreational use of mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity. J Med Toxicol 6(3): 327-330.
30. Dargan P, Wood D (2010) Technical report on mephedrone, 2010. European Monitoring Centre for Drugs and Drug Addiction. Risk assessment report of a new psychoactive substance: 4-methylmethcathinone (mephedrone). EMCDDA, Lisbon.
31. Wood DM, Greene SL, Dargan PI (2011) Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone. Emerg Med J 28(4): 280-282.
32. Dickson AJ, Vorce SP, Levine B, Past MR (2010) Multiple-drug toxicity caused by the coadministration of 4-methylmethcathinone (mephedrone) and heroin. J Anal Toxicol 34(3): 162-168.
33. Maskell PD, De Paoli G, Seneviratne C, Pounder DJ (2011) Mephedrone (4-methylmethcathinone)-related deaths. J Anal Toxicol 35(3): 188-191.
34. Torrance H, Cooper G (2010) The detection of mephedrone (4-methylmethcathinone) in 4 fatalities in Scotland. Forensic Sci Int 202(1-3): e62-e63.
35. Regan L, Mitchelson M, Macdonald C (2010) Mephedrone toxicity in a Scottish emergency department. Emerg Med J. Epub ahead of print.
36. Henry JA, Fallon JK, Kicman AT, Hutt AJ, Cowan DA, Forsling M (1998) Low-dose MDMA ("ecstasy") induces vasopressin secretion. Lancet 351(9118): 1784.
37. Sammler EM, Foley PL, Lauder GD et al (2010) A harmless high? Lancet 376(9742): 742.
38. Wood DM, Davies S, Greene SL et al (2010) Case series of individuals with analytically confirmed acute mephedrone toxicity. Clin Toxicol (Phila) 48(9): 924-927.
39. Gustavsson D, Escher C (2009) Mephedrone-Internet drug which seems to have come and stay. Fatal cases in Sweden have drawn attention to previously unknown substance. Lakartidningen 106(43): 2769-2771.
40. Lusthof KJ, Oosting R, Maes A et al (2011) A case of extreme agitation after use of mephedrone in the Netherlands. Forensic Sci Int 206(1-3): e9395.
41. Wikström M, Thelander G, Nyström I, Kronstrand R (2010) Two fatal intoxications with the new designer drug methedrone (4-methoxymethcathinone). J Anal Toxicol 34(9): 594-598.
42. Carter N, Rutty GN, Milroy CM, Forrest AR (2000) Deaths associated with MBDB misuse. Int J Legal Med 113(3): 168-170.
43. Zaitsu K, Katagi M, Tatsuno M et al (2011) Recently abused b-keto derivates of 3, 4-methylenedioxyphenylalkylamines: a review of their metabolisms and toxciological analysis. Forensic Toxicol 29(2): 73-84.
44. Cozzi NV, Sievert MK, Shulgin AT et al (1999) Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines. Eur J Pharmacol 381(1): 63-69.
45. Dal Cason TA, Young R, Glennon RA (1997) Cathinone: an investigation of several N-alkyl and methylenedioxy-substituted analogs. Pharmacol Biochem Behav 58(4): 1109-1116.
46. Sogawa C, Sogawa N, Ohyama K et al (2011) Methylone and monoamine transporters: correlation with toxicitiy. Curr Neuropharmacol 9: 58-62.
47. Nagai F, Nonaka R, Satoh Hisashi Kamimura K (2007) The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. Eur J Pharmacol 559(2-3): 132-137.
48. Kehr J, Ichinose F, Yoshitake S et al (2011) Mephedrone, compared to MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and serotonin levels in nucleus accumbens of awake rats. Br J Pharmacol. Epub ahead of print.
49. Bonnet JJ, Protais P, Chagraoui A, Costentin J (1986) High-affinity [3H]GBR 12783 binding to a specific site associated with the neuronal dopamine uptake complex in the central nervous system. Eur J Pharmacol 126(3): 211-222.
50. Servin A, Fauquet JP, Jacquot C, Rapin JR (1978) Effects of pyrovalerone on peripheral noradrenergic mechanisms. Biochem Pharmacol 27(12): 1693-1694.
51. Vaugeois JM, Bonnet JJ, Costentin J (1992) In vivo labelling of the neuronal dopamine uptake complex in the mouse striatum by [3H]GBR 12783. Eur J Pharmacol 210(1): 77-84.
52. Meltzer PC, Butler D, Deschamps JR, Madras BK (2006) 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors. J Med Chem 49(4): 1420-1432.
53. Michaelis W, Russel JH, Schindler O (1970) The metabolism of pyrovalerone hydrochloride. J Med Chem 13(3): 497-503.
54. Zaitsu K, Katagi M, Kamata HT et al (2009) Determination of the metabolites of the new designer drugs bk-MBDB and bk-MDEA in human urine. Forensic Sci Int 188(1-3): 131-139.
55. Kamata HT, Shima N, Zaitsu K et al (2006) Metabolism of the recently encountered designer drug, methylone, in humans and rats. Xenobiotica 36(8): 709-723.
56. Meyer MR, Wilhelm J, Peters FT, Maurer HH (2010) Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry. Anal Bioanal Chem 397(3): 1225-1233.
57. Strano-Rossi S, Cadwallader AB, de la Torre X, Botrè F (2010) Toxicological determination and in vitro metabolism of the designer drug methylenedioxypyrovalerone (MDPV) by gas chromatography/mass spectrometry and liquid chromatography/quadrupole time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 24(18): 2706-2714.
58. Meyer MR, Du P, Schuster F, Maurer HH (2010) Studies on the metabolism of the α-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC-MS and LC-high-resolution MS and its detectability in urine by GC-MS. J Mass Spectrom 45(12): 1426-1442.
59. Nakagawa Y, Suzuki T, Tayama S, Ishii H, Ogata A (2009) Cytotoxic effects of 3, 4-methylenedioxy-N-alkylamphetamines, MDMA and its analogues, on isolated rat hepatocytes. Arch Toxicol 83(1): 69-80.
60. Bajaj N, Mullen D, Wylie S (2010) Dependence and psychosis with 4-methylmethcathinone (mephedrone) use. BMJ Case Reports. Epub ahead of print.
61. Erowid. http://www. erowid. org/chemicals/4_methylmethcathinone/4_methylmethcathinone_effects. shtml Last accessed 7/12/2010.
62. Schifano F, Albanese A, Fergus S et al (2011) Mephedrone (4-methylmethcathinone; 'meow meow'): chemical, pharmacological and clinical issues. Psychopharmacology 214(3): 593-602.
63. Frison G, Gregio M, Zamengo L et al (2011) Gas chromatography/mass spectrometry determination of mephedrone in drug seizures after derivatization with 2, 2, 2-trichloroethyl chloroformate. Rapid Commun Mass Spectrom 25(2): 387-390.
64. Maheux CR, Copeland CR (2010) Characterization of three methcathinone analogs: 4-methylmethcathinone, methylone, and bk-MBDB. DEA Microgram J 7(2): 42-49.
65. Wissenbach DK, Meyer MR, Remane D, Philipp AA, Weber AA, Maurer HH (2011) Drugs of abuse screening in urine as part of a metabolite-based LC-MS(n) screening concept. Anal Bioanal Chem 400(10): 3481-3489.
66. Kikura-Hanajiri R, Kawamura M, Saisho K, Kodama Y, Goda Y (2007) The disposition into hair of new designer drugs; methylone, MBDB and methcathinone. J Chromatogr B Analyt Technol Biomed Life Sci 855(2): 121-126.
67. Federal Analogue Act. Controlled Substance Analogue Enforcement Act of 1986, Pub. L. No. 99-570, § 1203, 100 Stat. 3207, 3213-14.
68. DEA moves to emergency control synthetic stimulants. http://www. justice. gov/dea/pubs/pressrel/pr090711. html. Last accessed 09/07/2011.
69. Europa. Commission achieves EU-wide ban on ecstasy-like drug mephedrone http://europa. eu/rapid/pressReleasesAction. do?reference=MEMO/10/646. Last accessed 6/14/2010.
70. Frolich S, Lambe E, O'Dea J (2011) Acute liver failure following recreational use of psychotropic "head shop" compounds. Ir J Med Sci 180(1): 263-264.
71. Nicholson PJ, Quinn MJ, Dodd JD (2010) Headshop heartache: acute mephedrone 'meow' myocarditis. Heart 96(24): 2051-2052.
72. Shimizu E, Watanabe H, Kojima T et al (2007) Combined intoxication with methylone and 5-MeO-MIPT. Prog Neuropsychopharmacol Biol Psychiatry 31(1): 288-291.